CAS: 849753-15-7
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | N-[(1S)-1-(3-Fluorophenyl)-3-[(1R,5S)-3-[2-methyl-5-(2-methylpropanoyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridin-1-yl]-8-azabicyclo[3.2. 1]octan-8-yl]propyl]acetamide REF: 3D-ZIB75315CAS: 849753-15-7 | Min. 95% | 19.706,00 € | Ter 18 Fev 25 |
 | PF-232798 REF: TM-T28381CAS: 849753-15-7 | - - - | 2.617,00 €~4.741,00 € | Seg 24 Fev 25 |
N-[(1S)-1-(3-Fluorophenyl)-3-[(1R,5S)-3-[2-methyl-5-(2-methylpropanoyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridin-1-yl]-8-azabicyclo[3.2. 1]octan-8-yl]propyl]acetamide
CAS:849753-15-7
N-[(1S)-1-(3-Fluorophenyl)-3-[(1R,5S)-3-[2-methyl-5-(2-methylpropanoyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridin-1-yl]-8-azabicyclo[3.2. 1]octan-8-yl]propyl]acetamide is a research tool for use in cell biology and pharmacology studies. It …
Fórmula:
C29H40FN5O2
Pureza:
Min. 95%
Peso molecular:
509.7 g/mol
Ref: 3D-ZIB75315
| 500mg | 19.706,00 € |
Entrega estimada em Estados Unidos, Terça-feira 18 de Fevereiro de 2025
PF-232798
CAS:849753-15-7
PF-232798 is a second generation oral CCR5 antagonist with potent broad-spectrum anti-HIV-1 activity.
Fórmula:
C29H40FN5O2
Cor e Forma:
Solid
Peso molecular:
509.66
Ref: TM-T28381
| 25mg | 2.617,00 € | ||
| 50mg | 3.446,00 € | ||
| 100mg | 4.741,00 € |
Entrega estimada em Estados Unidos, Segunda-feira 24 de Fevereiro de 2025
